Cost-effectiveness of nutritional counseling for obese patients and patients at risk of ischemic heart disease.

作者: Jens Olsen , Ingrid Willaing , Steen Ladelund , Torben Jørgensen , Jens Gundgaard

DOI: 10.1017/S0266462305050269

关键词:

摘要: Objectives: Obesity and dyslipidemia are risk factors for ischemic heart disease, prevention treatment in primary care can reduce these risks. The objective of this cost-effectiveness analysis was to compare the costs effects (in terms life years gained) providing nutritional counseling by a general practitioner (GP) or dietician. Methods: A total 60 GPs, who accepted participate, were randomized either give refer patients dietician counseling. gained estimated using Cox regression model. Costs on basis registered use time (dieticians) agreed salaries (GPs). Results: effect comparing GPs dieticians is greatest when performed GP—0.0919 versus 0.0274 years. These appear be moderate, but they significant. It also proven that GP group most cost-effective—the cost gaining 1 extra year 8,213 DKK compared with group, which incremental ratio 59,987 DKK. Conclusions: other studies patient groups interventions report within same magnitude. cost-effective, it must concluded both strategies relatively cost-effective. Even though an might acceptable price.

参考文章(13)
David Wood, Guy De Backer, Ole Faergeman, Ian Graham, Giuseppe Mancia, Kalevi Pyörälä, Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis. ,vol. 140, pp. 199- 270 ,(1998) , 10.1016/S0021-9150(98)90209-X
David R. Cox, Regression Models and Life-Tables Springer Series in Statistics. ,vol. 34, pp. 527- 541 ,(1992) , 10.1007/978-1-4612-4380-9_37
Gillian D. Sanders, Al V. Taira, Cost Effectiveness of a Potential Vaccine for Human papillomavirus Emerging Infectious Diseases. ,vol. 9, pp. 37- 48 ,(2003) , 10.3201/EID0901.020168
Dorte Gyrd-Hansen, Willingness to pay for a QALY Health Economics. ,vol. 12, pp. 1049- 1060 ,(2003) , 10.1002/HEC.799
Andreas Maetzel, J??rg Ruof, Melva Covington, Anne Wolf, Economic evaluation of orlistat in overweight and obese patients with type 2 diabetes mellitus. PharmacoEconomics. ,vol. 21, pp. 501- 512 ,(2003) , 10.2165/00019053-200321070-00005
T. F. Thomsen, M. Davidsen, H. Ibsen, T. Jorgensen, G. Jensen, K. Borch-Johnsen, A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk Score. Journal of Cardiovascular Risk. ,vol. 8, pp. 291- 297 ,(2001) , 10.1177/174182670100800508